WGS logo

GeneDx Holdings Corp. (WGS)

$34.51

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on WGS

Market cap

$1.02B

EPS

-0.73

P/E ratio

--

Price to sales

4.72

Dividend yield

--

Beta

2.08745

Price on WGS

Previous close

$67.93

Today's open

$36.94

Day's range

$32.84 - $37.46

52 week range

$32.84 - $170.87

Profile about WGS

CEO

Katherine Stueland

Employees

1000

Headquarters

Stamford, CT

Exchange

Nasdaq Global Select

Shares outstanding

29688027

Issue type

Common Stock

WGS industries and sectors

Healthcare

Medical Diagnostics & Screening

News on WGS

INVESTOR ALERT: Investigation of GeneDx Holdings Corp. (WGS) announced by Holzer & Holzer, LLC

ATLANTA, May 06, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) complied with federal securities laws. On May 4, 2026, GeneDx reported its first quarter 2026 results and revised its guidance. Total revenue was $12 million lower than expected, which the Company attributed to: “mix dynamics resulting in a lower-than-expected blended average reimbursement rate and softer noncore business line performance.” The price of the Company's stock dropped following this news.

news source

GlobeNewsWire • 11 hours ago

news preview

GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GENEDX HOLDINGS CORP. (WGS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by.

news source

Business Wire • 17 hours ago

news preview

Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON GENEDX HOLDINGS CORP. (WGS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On M.

news source

Business Wire • 14 hours ago

news preview

GENEDX HOLDINGS CORP. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ:WGS). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 4, 2026, GeneDx released its first quarter 2026 financial results, revealing earnings per sha.

news source

Business Wire • 6 hours ago

news preview

GeneDX Holdings Investigated for Possible Securities Fraud; Investors Should Contact Block & Leviton to Recover Losses

Boston, Massachusetts--(Newsfile Corp. - May 6, 2026) - Block & Leviton is investigating GeneDX Holdings Corp. (NASDAQ: WGS) for potential securities law violations. Investors who have lost money in their GeneDX Holdings Corp. investment should contact the firm to learn more about how they might recover those losses.

news source

Newsfile Corp • 10 hours ago

news preview

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Ark Invest added to existing positions in Shopify, Intellia Therapeutics, and GeneDX on Tuesday. Shopify stock surrendered 16% of its value after posting disappointing quarterly results.

news source

The Motley Fool • 16 hours ago

news preview

The 'Alarming' Results That Caused GeneDx Stock To Plummet 45%

GeneDx stock crashed Tuesday on what one analyst called its "alarming" first-quarter sales miss, leading to a guidance cut for the year.

news source

Investors Business Daily • May 5, 2026

news preview

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp.

MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against GeneDx (Nasdaq: WGS). The investigation results from inaccurate statements GeneDx may have made regarding its financial statements, business operations and prospects.

news source

PRNewsWire • May 5, 2026

news preview

Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON GENEDX HOLDINGS CORP. (WGS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is the Investigation About?On May 4, 2026, after market hours, GeneDx released its first quarte.

news source

Business Wire • May 5, 2026

news preview

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, May 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of GeneDx Holdings Corp. (NASDAQ: WGS). The investigation focuses on GeneDx's executive officers and whether investor losses may be recovered under federal securities laws.

news source

GlobeNewsWire • May 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in GeneDx Holdings Corp.

Open an M1 investment account to buy and sell GeneDx Holdings Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in WGS on M1